␦-N-acetyl-L-␦-N-hydroxyornithine and three glycine resi- trast to albomycin, rifamycin CGP 4832 is not actively transported across the cytoplasmic membrane by FhuBCD [9] , which is an ABC transport system [10] . The were derived from the isomorphous, unliganded strucperiplasmic binding protein FhuD and the cytoplasmic ture ( Figure 1 ; Table 1 ; [4] ). After initial structural refinemembrane-embedded permease FhuBC effectively disment, a F obs Ϫ F calc difference map showed clear electron criminate between rifamycin CGP 4832 and the diverse density for a single rifamycin CGP 4832 molecule loarray of hydroxamate-type siderophores and antibiotics cated within the extracellular pocket of FhuA (Figure that are uniquely transported by this system [3] . Because the chemical structure of this rifamycin derivative shares no structural similarities with ferrichrome or with albomycin, we wished to determine how this antibiotic is specifically recognized and transported by FhuA. To establish whether it occupies the same ligand binding site as previously observed with hydroxamate-type siderophores and to characterize any distinct ligandinduced conformational changes, we determined the three-dimensional structure of FhuA in complex with rifamycin CGP 4832. Furthermore, we also studied the binding of ligands to FhuA by fluorescence measurements, transport inhibition, and selection of mutants resistant to this antibiotic. Our findings reveal common structural and mechanistic requirements for the energydependent transport of structurally dissimilar FhuA-specific ligands. Moreover, this structural information provides a basis for the rational design of synthetic antibiotics that are actively transported by this receptor or by its homologs. Because the outer membrane of gram-negative bacteria is inherently impermeable to polar substances Ͼ600 Da and therefore diffusional uptake is inefficient, such receptor-specific bactericidal agents may increase the efficacy of chemotherapeutic agents [7] . 
Results
The view is perpendicular to the barrel axis. The ␤ strands that form the front of the barrel domain have been rendered semitransparent; Table 2 ). The addition of morpholino and N-methyl-3-piperidyl-acetoxyacetyl 3b) and ferricrocin (Figure 3c ). Moreover, the cork domain structure in the FhuA-CGP 4832 complex differs groups structurally distinguishes rifamycin CGP 4832 from rifamycin; the latter is not actively transported by from that found in complexes with hydroxamate-type siderophores and albomycin. By comparing the side FhuA. Previous structure-function studies [8] demonstrated that both chemical moieties are required for the chains involved in the binding of these structurally dissimilar substrates, we identified signature residues that rifamycin derivative to exert its bactericidal activity. Our analysis of protein-ligand interactions between FhuA are involved in ligand binding ( Table 3 ). The iron-chelating moiety of FhuA-specific hydroxamate-type sidero-and rifamycin CGP 4832 showed that the morpholino and N-methyl-3-piperidyl-acetoxyacetyl groups form phores and albomycin is formed by three ␦-N-acetyl-
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L-␦-N-hydroxyornithine peptides. This portion of the multiple hydrogen bonds, charge interactions, and van der Waals contacts with FhuA side chains (Figures 2b
siderophore forms multiple highly conserved interactions with side chains from apices A, B, and C of the and 3a; Table 2 ). Chemical replacement of the morpholino moiety by a methyl-piperazinyl-iminomethyl substit-cork domain, as well as with residues from the ␤ strands and extracellular loops of the barrel domain (Figures 3b uent abolished the bactericidal activity of rifamycin CGP 4832 [9] . The structure indicated that substitution of and 3c). There are also contacts between the tripeptide component of the siderophore (GGG [ferrichrome], GSG the morpholino group would prevent the formation of a critical hydrogen bond between rifamycin CGP 4832 and
[ferricrocin], GFG [phenylferricrocin]) and the amino acetyl thioribosyl pyrimidine moiety of albomycin, with side Y116 from apex C and would thereby abrogate highaffinity binding.
chains of the extracellular pocket (Table 3) . A similar set Figure 5b ). However, the magnitude of the fluorescence quenching was not upward (0.5-1.5 Å ) to interact with the antibiotic ( Table  2 ). All other cork domain residues remained stationary. equivalent to that observed with FhuA. The addition of rifamycin CGP 4832 or desferriferrichrome to the trypto-In the complexes with iron-hydroxamates, the upward translation of apex A is propagated to all cork domain phan solution also failed to produce a similar effect (Figure 5b ).
loops between this point and the periplasmic pocket of FhuA. The translation of apex A and other cork domain
A second biophysical method for monitoring ligandinduced structural transitions in FhuA was provided by loops alters the shape of the hydrophobic pocket of the switch helix (residues 24-29), disrupts several hydrogen the measurement of fluorescence changes of fluores-cein-labeled cysteine residues. This technique has advantages in that the location of the reporter is known and in that data can be collected directly from viable, intact cells. It was shown previously [12] that ferrichrome binding to FhuA quenched the emitted fluorescence of two fluorescein-labeled cysteines, residues 329 and 336, which are located in the fourth extracellular loop according to the three-dimensional structure of FhuA. Rifamycin CGP 4832 binding caused a similar reduction in fluorescence of both surface-exposed cysteines. However, a 100-fold higher concentration of rifamycin CGP 4832 was required to obtain a similar ferrichrome bound spectrum ( Table 4 ). The observed fluorescence quenching by rifamycin CGP 4832 was not a function of the TonB-dependent transport of this antibiotic through FhuA since identical spectra were obtained from tonBdeleted background strains (data not shown). The binding of ferrichrome to FhuA also induced a similar TonBindependent shift in fluorescence [12].
Rifamycin CGP 4832 Competes with Ferrichrome for Binding to the Ligand Binding Site of FhuA
To probe the functional implications resulting from the similarity of the binding sites for rifamycin CGP 4832 and ferrichrome, we performed transport inhibition assays. The addition of 10, 30, or 100 g/ml of rifamycin CGP 4832 produced a 50%, 75%, or 85% reduction in the [ 55 Fe 3ϩ ]-ferrichrome transport rate ( Figure 6) . These data indicate that this antibiotic competes with ferrichrome for the same binding site and that both substrates have similar binding affinities. Because rifamycin CGP 4832 does not use the FhuBCD ferrichrome transport system across the cytoplasmic membrane, competitive transport inhibition is confined to passage across the outer membrane only [9] .
Bacterial Mutants Resistant to Rifamycin CGP 4832
To determine if the energy-dependent transport of rifamycin CGP 4832 and ferrichrome share common structural requirements, we assessed the sensitivity for the antibiotic of cells expressing FhuA proteins with known point mutations in their TonB boxes (residues 6-11); these mutations all exhibit impaired TonB-related FhuA activity [13]. Plasmid-encoded fhuA genes were used to transform E. coli UL3, which does not synthesize a wild-type FhuA protein. In contrast to cells expressing wild-type FhuA, those producing FhuA mutants I9P or V11D showed resistance to 0.4-10 g/ml of rifamycin CGP 4832. The antibiotic sensitivity of mutant and wildtype cells for rifamycin CGP 4832 and rifamycin were Table 2 for details of additional van der Waals contacts between side chains and rifamycin CGP 4832. 
Interaction of TonB with FhuA and the Functional Consequences
The pronounced allosteric transition observed in hydroxamate-type ligand binding presumably serves to recruit the energy-transducing protein TonB to the TonB box, its principal site of known interaction with TonB-dependent transporters. Relocation of this highly conserved segment is likely required for efficient coupling of TonB with FhuA. This NH 2 -proximal region of FhuA is localized in the periplasm and has been shown by genetic and biochemical means to interact physically with a region of TonB at or near residue 160 [13, 16]. The failure to visualize this segment of FhuA (residues 6-11) in any of the currently available electron density maps [4, 5, 7] agrees with its apparent flexibility. However, the solution of the three-dimensional structure of the ferric entero- conformation the TonB box of BtuB may be localized adjacent to a helix that forms specific interactions with side chain residues from the periplasmic turns of the ␤ Given the TonB dependence of rifamycin CGP 4832 transport as shown in [9] and the data presented here, barrel domain of the receptor [19] . The binding of vitamin B 12 converted this segment into an extended, disor-FhuA may assume two conformations that are in equilibrium. The majority of FhuA molecules have wound switch dered, and highly dynamic structure that likely extends into the periplasm to interact physically with TonB. Col-helices, while a small fraction contain unwound switch helices. Under crystal growth conditions, this equilib-lectively, these findings support the proposal that the unwinding of the switch helix promotes the formation rium may be skewed toward the helical conformation; however, in vivo a small percentage of FhuA proteins of the FhuA-TonB complex in vivo, and this may be an essential mechanistic requirement for the coupling of may be sufficient for the formation of transport-competent complexes with TonB and may thereby sustain the the proton motive force of the cytoplasmic membrane with receptor-mediated ligand transport across the observed transport rate. Alternatively, the physical interaction of TonB with the destabilized switch helix may outer membrane. an induced-fit mechanism at a low rate. We suggest that this small yield of productive complexes among 
Bacterial cells that synthesize the deletion derivative FhuA⌬5-160 retain a diminished level of TonB-depen-
